benzo(a)pyrene-3,6-quinol has been researched along with bmy 25067 in 1 studies
Studies (benzo(a)pyrene-3,6-quinol) | Trials (benzo(a)pyrene-3,6-quinol) | Recent Studies (post-2010) (benzo(a)pyrene-3,6-quinol) | Studies (bmy 25067) | Trials (bmy 25067) | Recent Studies (post-2010) (bmy 25067) |
---|---|---|---|---|---|
5 | 0 | 0 | 21 | 2 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Celli, CM; Jaiswal, AK; Knox, R; Tran, N | 1 |
1 other study(ies) available for benzo(a)pyrene-3,6-quinol and bmy 25067
Article | Year |
---|---|
NRH:quinone oxidoreductase 2 (NQO2) catalyzes metabolic activation of quinones and anti-tumor drugs.
Topics: Animals; Antineoplastic Agents; Aziridines; Benzopyrenes; Biotransformation; Cell Survival; Cells, Cultured; CHO Cells; Cricetinae; Cricetulus; Cross-Linking Reagents; DNA, Complementary; Dose-Response Relationship, Drug; Hydroquinones; Indolequinones; Keratinocytes; Mice; Mice, Knockout; Mitomycin; Mitomycins; Quinone Reductases; Quinones; Transfection; Vitamin K 3 | 2006 |